OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Protein arginine N-methyltransferase 5 in colorectal carcinoma: Insights into mechanisms of pathogenesis and therapeutic strategies
Wafaa Abumustafa, Batoul Abi Zamer, Bariaa Khalil, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112368-112368
Open Access | Times Cited: 13
Wafaa Abumustafa, Batoul Abi Zamer, Bariaa Khalil, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112368-112368
Open Access | Times Cited: 13
Showing 13 citing articles:
Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies
Jiahong Zheng, Bang Li, Yingqi Wu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8407-8427
Closed Access | Times Cited: 28
Jiahong Zheng, Bang Li, Yingqi Wu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8407-8427
Closed Access | Times Cited: 28
Medicinal chemistry strategies targeting PRMT5 for cancer therapy
Siyu Fu, Qinwen Zheng, Dan Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114842-114842
Closed Access | Times Cited: 24
Siyu Fu, Qinwen Zheng, Dan Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114842-114842
Closed Access | Times Cited: 24
Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer
Shuangjie Liu, Zhuonan Liu, Chiyuan Piao, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Shuangjie Liu, Zhuonan Liu, Chiyuan Piao, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment
Faranak Alipourgivi, Aishat Motolani, A. Qiu, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 154-154
Open Access | Times Cited: 6
Faranak Alipourgivi, Aishat Motolani, A. Qiu, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 154-154
Open Access | Times Cited: 6
Mechanistic aspects of reversible methylation modifications of arginine and lysine of nuclear histones and their roles in human colon cancer
Ankan Roy, Niharika Niharika, Subhajit Chakraborty, et al.
Progress in molecular biology and translational science (2023), pp. 261-302
Closed Access | Times Cited: 5
Ankan Roy, Niharika Niharika, Subhajit Chakraborty, et al.
Progress in molecular biology and translational science (2023), pp. 261-302
Closed Access | Times Cited: 5
Tricyclic Carboxamide Derivatives as PRMT5 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 8, pp. 1204-1205
Open Access | Times Cited: 9
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 8, pp. 1204-1205
Open Access | Times Cited: 9
Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancer
Yao Shen, Pan Zhao, Kewei Dong, et al.
Cancer & Metabolism (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Yao Shen, Pan Zhao, Kewei Dong, et al.
Cancer & Metabolism (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 7
SMYD3 regulates gastric cancer progression and macrophage polarization through EZH2 methylation
Peng Wang, Liang Zhao, Yiqi Rui, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 4, pp. 575-581
Closed Access | Times Cited: 5
Peng Wang, Liang Zhao, Yiqi Rui, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 4, pp. 575-581
Closed Access | Times Cited: 5
Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells
Shayaan Rasheed, Renee A. Bouley, Ryan J. Yoder, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6042-6042
Open Access | Times Cited: 2
Shayaan Rasheed, Renee A. Bouley, Ryan J. Yoder, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6042-6042
Open Access | Times Cited: 2
PRMT5 Mediated HIF1α Signaling and Ras-Related Nuclear Protein as Promising Biomarker in Hepatocellular Carcinoma
Wafaa Abumustafa, Darko Castven, Fatemeh Saheb Sharif‐Askari, et al.
Biology (2024) Vol. 13, Iss. 4, pp. 216-216
Open Access
Wafaa Abumustafa, Darko Castven, Fatemeh Saheb Sharif‐Askari, et al.
Biology (2024) Vol. 13, Iss. 4, pp. 216-216
Open Access
Targeting PRMT5 enhances the radiosensitivity of tumor cells grown in vitro and in vivo
Charlotte Degorre, Steven Lohard, Christina N. Bobrek, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Charlotte Degorre, Steven Lohard, Christina N. Bobrek, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Targeting Non-histone Methylation in Gastrointestinal Cancers: From biology to clinic
Zhanbo Sun, Lixian Liu, Jun Chen
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116802-116802
Closed Access
Zhanbo Sun, Lixian Liu, Jun Chen
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116802-116802
Closed Access
The Role of Protein Arginine Methyltransferases in Pathogenesis and Treatment of Digestive System Carcinoma
Bin Wang, Dong Ding, Xiaoan Zhang, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 8, pp. 926-935
Open Access | Times Cited: 1
Bin Wang, Dong Ding, Xiaoan Zhang, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 8, pp. 926-935
Open Access | Times Cited: 1
